NDC 22840-1685
Gliocladium viride
Gliocladium Viride
Gliocladium viride is a Intradermal; Percutaneous; Subcutaneous Solution in the Non-standardized Allergenic category. It is labeled and distributed by Greer Laboratories, Inc.. The primary component is Gliocladium Viride.
| Product ID | 22840-1685_77436178-2957-6a77-e053-2a91aa0a873e |
| NDC | 22840-1685 |
| Product Type | Non-standardized Allergenic |
| Proprietary Name | Gliocladium viride |
| Generic Name | Gliocladium Viride |
| Dosage Form | Solution |
| Route of Administration | INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS |
| Marketing Start Date | 1981-09-15 |
| Marketing Category | BLA / BLA |
| Application Number | BLA101833 |
| Labeler Name | Greer Laboratories, Inc. |
| Substance Name | GLIOCLADIUM VIRIDE |
| Active Ingredient Strength | 20000 [PNU]/mL |
| Pharm Classes | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |